Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Eagle Health Holdings

ASX:EHH
Snowflake Description

Adequate balance sheet and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
EHH
ASX
A$53M
Market Cap
  1. Home
  2. AU
  3. Household
Company description

Eagle Health Holdings Limited develops, produces, markets, and distributes health food products, and nutritional and dietary supplements in China. The last earnings update was 30 days ago. More info.


Add to Portfolio Compare Print
  • Eagle Health Holdings has significant price volatility in the past 3 months.
EHH Share Price and Events
7 Day Returns
3.6%
ASX:EHH
2.5%
AU Personal Products
0.3%
AU Market
1 Year Returns
-49.1%
ASX:EHH
-28.7%
AU Personal Products
-22.9%
AU Market
EHH Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Eagle Health Holdings (EHH) 3.6% -19.4% 16% -49.1% - -
AU Personal Products 2.5% -12.3% -24.4% -28.7% -40.4% -10.6%
AU Market 0.3% -27.8% -30% -22.9% -20.8% -20.3%
1 Year Return vs Industry and Market
  • EHH underperformed the Personal Products industry which returned -28.7% over the past year.
  • EHH underperformed the Market in Australia which returned -22.9% over the past year.
Price Volatility
EHH
Industry
5yr Volatility vs Market

Value

 Is Eagle Health Holdings undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Eagle Health Holdings to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Eagle Health Holdings.

ASX:EHH Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model Dividend Discount Model
Dividend Per Share Company Filings (2019-12-31) in AUD A$ .001200
Payout Ratio Company Filings (2019-12-31) 1179.8%
Discount Rate (Cost of Equity) See below 6.1%
Perpetual Growth Rate 10-Year AU Government Bond Rate 1.1%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for ASX:EHH
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year AU Govt Bond Rate 1.1%
Equity Risk Premium S&P Global 6.3%
Personal Products Unlevered Beta Simply Wall St/ S&P Global 0.6
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.599 (1 + (1- 25%) (17.56%))
0.691
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.8
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.08% + (0.8 * 6.33%)
6.14%

Discounted Cash Flow Calculation for ASX:EHH using Dividend Discount Model Model

The calculations below outline how an intrinsic value for Eagle Health Holdings is arrived at by discounting future dividends to their present value. This approach is used for finance firms where free cash flow is difficult to estimate (e.g. Banks/ Insurance firms).

If the firm does not pay the majority of its earnings out as a dividend this method will often arrive at a value significantly lower than the share price.

See our documentation to learn about this calculation.

ASX:EHH Gordon Growth Model
Calculation Result
Value per share = Expected dividends per share / (Discount Rate - Perpetual growth rate)
= A$0 / (6.14% - 1.08%)
A$0.02
ASX:EHH Discount to Share Price
Calculation Result
Value per share (AUD) From above. A$0.02
Current discount Discount to share price of A$0.15
= -1 x (A$0.15 - A$0.02) / A$0.02
-511.9%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Eagle Health Holdings is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Eagle Health Holdings's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Eagle Health Holdings's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
ASX:EHH PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in AUD A$0.03
ASX:EHH Share Price ** ASX (2020-03-27) in AUD A$0.15
Australia Personal Products Industry PE Ratio Median Figure of 5 Publicly-Listed Personal Products Companies 18.5x
Australia Market PE Ratio Median Figure of 514 Publicly-Listed Companies 12.59x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Eagle Health Holdings.

ASX:EHH PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= ASX:EHH Share Price ÷ EPS (both in AUD)

= 0.15 ÷ 0.03

5.5x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Eagle Health Holdings is good value based on earnings compared to the AU Personal Products industry average.
  • Eagle Health Holdings is good value based on earnings compared to the Australia market.
Price based on expected Growth
Does Eagle Health Holdings's expected growth come at a high price?
Raw Data
ASX:EHH PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 5.5x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Global Personal Products Industry PEG Ratio Median Figure of 69 Publicly-Listed Personal Products Companies 1.96x
Australia Market PEG Ratio Median Figure of 337 Publicly-Listed Companies 0.97x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Eagle Health Holdings, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Eagle Health Holdings's assets?
Raw Data
ASX:EHH PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in AUD A$0.26
ASX:EHH Share Price * ASX (2020-03-27) in AUD A$0.15
Australia Personal Products Industry PB Ratio Median Figure of 10 Publicly-Listed Personal Products Companies 1.97x
Australia Market PB Ratio Median Figure of 1,615 Publicly-Listed Companies 1.16x
ASX:EHH PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= ASX:EHH Share Price ÷ Book Value per Share (both in AUD)

= 0.15 ÷ 0.26

0.56x

* Primary Listing of Eagle Health Holdings.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Eagle Health Holdings is good value based on assets compared to the AU Personal Products industry average.
X
Value checks
We assess Eagle Health Holdings's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Personal Products industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Personal Products industry average (and greater than 0)? (1 check)
  5. Eagle Health Holdings has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Eagle Health Holdings expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Eagle Health Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
28%
Expected Personal Products industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Eagle Health Holdings expected to grow at an attractive rate?
  • Unable to compare Eagle Health Holdings's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Eagle Health Holdings's earnings growth to the Australia market average as no estimate data is available.
  • Unable to compare Eagle Health Holdings's revenue growth to the Australia market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
ASX:EHH Future Growth Rates Data Sources
Data Point Source Value (per year)
Australia Personal Products Industry Earnings Growth Rate Market Cap Weighted Average 28%
Australia Personal Products Industry Revenue Growth Rate Market Cap Weighted Average 6.2%
Australia Market Earnings Growth Rate Market Cap Weighted Average 9.7%
Australia Market Revenue Growth Rate Market Cap Weighted Average 4%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
ASX:EHH Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in AUD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
ASX:EHH Past Financials Data
Date (Data in AUD Millions) Revenue Cash Flow Net Income *
2019-12-31 103 -25 9
2019-09-30 109 -26 12
2019-06-30 114 -27 16
2019-03-31 112 -14 18
2018-12-31 111 -1 19
2018-09-30 103 6 16
2018-06-30 95 13 13
2018-03-31 92 12 13
2017-12-31 89 12 13
2017-09-30 88 12 14
2017-06-30 87 12 15
2017-03-31 86 15 15

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Eagle Health Holdings is high growth as no earnings estimate data is available.
  • Unable to determine if Eagle Health Holdings is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
ASX:EHH Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Eagle Health Holdings Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:EHH Past Financials Data
Date (Data in AUD Millions) EPS *
2019-12-31 0.03
2019-09-30 0.04
2019-06-30 0.05
2019-03-31 0.06
2018-12-31 0.06
2018-09-30 0.05
2018-06-30 0.04
2018-03-31 0.05
2017-12-31 0.05
2017-09-30 0.06
2017-06-30 0.07
2017-03-31 0.07

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Eagle Health Holdings will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine whether Eagle Health Holdings is trading at Eagle Health Holdings'san attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
  2. Eagle Health Holdings's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Household companies here
  3. Eagle Health Holdings's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Eagle Health Holdings's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Australia market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Australia market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Eagle Health Holdings has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Eagle Health Holdings performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Eagle Health Holdings's growth in the last year to its industry (Personal Products).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Eagle Health Holdings's year on year earnings growth rate has been positive over the past 5 years, however the most recent earnings are below average.
  • Eagle Health Holdings's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Eagle Health Holdings's 1-year earnings growth is negative, it can't be compared to the AU Personal Products industry average.
Earnings and Revenue History
Eagle Health Holdings's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Eagle Health Holdings Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

ASX:EHH Past Revenue, Cash Flow and Net Income Data
Date (Data in AUD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 103.20 8.51 24.90 3.90
2019-09-30 108.51 12.45 25.04 3.73
2019-06-30 113.81 16.40 25.19 3.57
2019-03-31 112.41 17.57 24.75 3.21
2018-12-31 111.01 18.73 24.30 2.86
2018-09-30 103.06 15.91 23.76 2.77
2018-06-30 95.11 13.08 23.22 2.69
2018-03-31 92.16 13.14 21.77 2.85
2017-12-31 89.22 13.20 20.31 3.00
2017-09-30 88.11 14.07 19.66 2.92
2017-06-30 87.01 14.94 19.01 2.84
2017-03-31 85.57 15.40 18.73 2.74
2016-12-31 84.12 15.85 18.46 2.65
2015-12-31 72.51 13.97 19.57
2014-12-31 50.57 8.74 13.15

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Eagle Health Holdings has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Eagle Health Holdings used its assets more efficiently than the AU Personal Products industry average last year based on Return on Assets.
  • Eagle Health Holdings's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Eagle Health Holdings's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Personal Products industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Eagle Health Holdings has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Eagle Health Holdings's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Eagle Health Holdings's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Eagle Health Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Eagle Health Holdings's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Eagle Health Holdings's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 7.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Eagle Health Holdings Company Filings, last reported 2 months ago.

ASX:EHH Past Debt and Equity Data
Date (Data in AUD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 85.01 9.21 8.57
2019-09-30 85.01 9.21 8.57
2019-06-30 78.37 9.33 13.69
2019-03-31 78.37 9.33 13.69
2018-12-31 75.67 9.28 32.69
2018-09-30 75.67 9.28 32.69
2018-06-30 61.77 6.00 37.32
2018-03-31 61.77 6.00 37.32
2017-12-31 55.01 5.79 34.91
2017-09-30 55.01 5.79 34.91
2017-06-30 47.26 5.26 32.06
2017-03-31 47.26 5.26 32.06
2016-12-31 20.25 5.48 5.19
2015-12-31
2014-12-31
  • Eagle Health Holdings's level of debt (10.8%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Eagle Health Holdings's debt level has increased without past 5-year debt data.
  • Operating cash flow is negative therefore debt is not well covered.
  • Interest payments on debt are well covered by earnings (EBIT is 23.1x coverage).
X
Financial health checks
We assess Eagle Health Holdings's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Eagle Health Holdings has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Eagle Health Holdings's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0.83%
Current annual income from Eagle Health Holdings dividends.
If you bought A$2,000 of Eagle Health Holdings shares you are expected to receive A$17 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Eagle Health Holdings's pays a lower dividend yield than the bottom 25% of dividend payers in Australia (3.35%).
  • Eagle Health Holdings's dividend is below the markets top 25% of dividend payers in Australia (8.5%).
Upcoming dividend payment

Purchase Eagle Health Holdings before the 'Ex-dividend' to receive their next dividend payment.

Dividends are usually paid every 3 or 6 months, you can time your share purchase to take advantage of upcoming dividend payments.
Dividend payment calendar
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
ASX:EHH Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Global Personal Products Industry Average Dividend Yield Market Cap Weighted Average of 142 Stocks 2.1%
Australia Market Average Dividend Yield Market Cap Weighted Average of 373 Stocks 5.8%
Australia Minimum Threshold Dividend Yield 10th Percentile 1.8%
Australia Bottom 25% Dividend Yield 25th Percentile 3.4%
Australia Top 25% Dividend Yield 75th Percentile 8.5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

ASX:EHH Past Annualized Dividends Data
Date (Data in A$) Dividend per share (annual) Avg. Yield (%)
2020-02-28 0.001 0.750
2019-03-05 0.005 2.966
2018-02-28 0.005 1.931
2017-08-30 0.005 1.451

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Eagle Health Holdings is not paying a notable dividend for Australia, therefore no need to check if the payments are stable.
  • Eagle Health Holdings is not paying a notable dividend for Australia, therefore no need to check if the payments are increasing.
Current Payout to shareholders
What portion of Eagle Health Holdings's earnings are paid to the shareholders as a dividend.
  • No need to calculate the sustainability of Eagle Health Holdings's dividends as it is not paying a notable one for Australia.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Eagle Health Holdings's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Eagle Health Holdings afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Eagle Health Holdings has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Eagle Health Holdings's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Mingwang Zhang
COMPENSATION A$173,541
AGE 55
TENURE AS CEO 3.3 years
CEO Bio

Mr. Mingwang Zhang is the Founder of the Eagle Group. Mr. Zhang serves as the Chief Executive Officer of Eagle Health Holdings Limited and has been its Executive Director since December 09, 2016. He was the Founder of Shenli Ginseng Co.,Ltd. From 1980 to 1985, Mr. Zhang was the Technical Expert at the Agricultural Bureau of Cangnan County (Wenzhou). He has more than 30 years of experience in the health food and nutritional supplements industry. He served as Chairman of Changbaishan City Ginseng Co.,Ltd. from 1995 to 2000. He served as Chairman of Tong’an Chamber of Food Business. He served as Standing Chair of the World Chinese Entrepreneur Association. He served as Vice Chairman of the Tong’an Chamber of Commerce; Standing Deputy Chairman of the Xiamen Health Food and Cosmetics Association; Standing Vice Chairman of Industry and Commerce Association, Tong’an District, Xiamen; and Standing Deputy Chairman of Wenzhou Commerce Association in Fujian Province. He acted as the research fellow of the Chinese People’s Political Consultative Conference Xiamen Committee. Mr. Zhang earned an EMBA degree from Xiamen University and Kellogg Business College, Northwest University, USA.

CEO Compensation
  • Mingwang's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Mingwang's remuneration is lower than average for companies of similar size in Australia.
Management Team Tenure

Average tenure and age of the Eagle Health Holdings management team in years:

1.4
Average Tenure
54
Average Age
  • The average tenure for the Eagle Health Holdings management team is less than 2 years, this suggests a new team.
Management Team

Mingwang Zhang

TITLE
CEO & Executive Director
COMPENSATION
A$174K
AGE
55
TENURE
3.3 yrs

Yandeng Que

TITLE
Chief Financial Officer
COMPENSATION
A$172K
TENURE
1.4 yrs

Linxiang Chen

TITLE
Vice General Manager
COMPENSATION
A$144K
AGE
53

Gang Xu

TITLE
MD & Executive Director
AGE
55

James de Kauwe

TITLE
Executive Director
AGE
42

Henko Vos

TITLE
Company Secretary
TENURE
0.3 yrs
Board of Directors Tenure

Average tenure and age of the Eagle Health Holdings board of directors in years:

0.3
Average Tenure
55
Average Age
  • The average tenure for the Eagle Health Holdings board of directors is less than 3 years, this suggests a new board.
Board of Directors

Andrew Smith

TITLE
Interim Chairman of the Board
COMPENSATION
A$53K
TENURE
0.3 yrs

Mingwang Zhang

TITLE
CEO & Executive Director
COMPENSATION
A$174K
AGE
55
TENURE
3.3 yrs

Gang Xu

TITLE
MD & Executive Director
AGE
55
TENURE
0.3 yrs

James de Kauwe

TITLE
Executive Director
AGE
42
TENURE
0.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (A$) Value (A$)
03. Jun 19 Sell Creator Global Holdings Limited Company 29. May 19 31. May 19 -33,290,000 A$0.25 A$-7,499,625
X
Management checks
We assess Eagle Health Holdings's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Eagle Health Holdings has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

What Is Eagle Health Holdings's (ASX:EHH) P/E Ratio After Its Share Price Tanked?

View our latest analysis for Eagle Health Holdings How Does Eagle Health Holdings's P/E Ratio Compare To Its Peers? … The Bottom Line On Eagle Health Holdings's P/E Ratio Eagle Health Holdings trades on a P/E ratio of 3.4, which is below the AU market average of 16.2. … Given Eagle Health Holdings's P/E ratio has declined from 5 to 3.4 in the last month, we know for sure that the market is more worried about the business today, than it was back then.

Simply Wall St -

What Percentage Of Eagle Health Holdings Limited (ASX:EHH) Shares Do Insiders Own?

See our latest analysis for Eagle Health Holdings ASX:EHH Ownership Summary, August 19th 2019 What Does The Lack Of Institutional Ownership Tell Us About Eagle Health Holdings? … Insider Ownership Of Eagle Health Holdings While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. … Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

Simply Wall St -

Those Who Purchased Eagle Health Holdings (ASX:EHH) Shares A Year Ago Have A 25% Loss To Show For It

For example, the Eagle Health Holdings Limited (ASX:EHH) share price is down 25% in the last year. … During the unfortunate twelve months during which the Eagle Health Holdings share price fell, it actually saw its earnings per share (EPS) improve by 14%. … A Different Perspective While Eagle Health Holdings shareholders are down 24% for the year (even including dividends), the market itself is up 12%.

Simply Wall St -

How Does Eagle Health Holdings's (ASX:EHH) P/E Compare To Its Industry, After Its Big Share Price Gain?

View our latest analysis for Eagle Health Holdings Does Eagle Health Holdings Have A Relatively High Or Low P/E For Its Industry? … We can tell from its P/E ratio of 5.24 that sentiment around Eagle Health Holdings isn't particularly high. … ASX:EHH Price Estimation Relative to Market, July 9th 2019 Its relatively low P/E ratio indicates that Eagle Health Holdings shareholders think it will struggle to do as well as other companies in its industry classification.

Simply Wall St -

Are Eagle Health Holdings Limited’s (ASX:EHH) High Returns Really That Great?

Analysts use this formula to calculate return on capital employed: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) Or for Eagle Health Holdings: 0.33 = AU$25m ÷ (AU$96m - AU$21m) (Based on the trailing twelve months to December 2018.) Therefore, Eagle Health Holdings has an ROCE of 33%. … What Are Current Liabilities, And How Do They Affect Eagle Health Holdings's ROCE? … Our Take On Eagle Health Holdings's ROCE Low current liabilities and high ROCE is a good combination, making Eagle Health Holdings look quite interesting.

Simply Wall St -

Eagle Health Holdings Limited (ASX:EHH) Has Attractive Fundamentals

For those interested in digger a bit deeper into my commentary, read the full report on Eagle Health Holdings here. … EHH's strong financial health means that all of its upcoming liability payments are able to be met by its current cash and short-term investment holdings. … ASX:EHH Income Statement, May 10th 2019 Next Steps: For Eagle Health Holdings, there are three fundamental aspects you should further examine: Future Outlook: What are well-informed industry analysts predicting for EHH’s future growth?

Simply Wall St -

The Eagle Health Holdings (ASX:EHH) Share Price Is Down 11% So Some Shareholders Are Getting Worried

Eagle Health Holdings Limited (ASX:EHH) shareholders will doubtless be very grateful to see the share price up 79% in the last quarter. … But that is minimal compensation for the share price under-performance over the last year. … Even though the Eagle Health Holdings share price is down over the year, its EPS actually improved.

Simply Wall St -

Why Eagle Health Holdings Limited’s (ASX:EHH) Return On Capital Employed Is Impressive

Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give us an insight into how efficiently the business can generate profits from the capital it requires. … Return On Capital Employed (ROCE): What is it? … ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business.

Simply Wall St -

Here's How P/E Ratios Can Help Us Understand Eagle Health Holdings Limited (ASX:EHH)

This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). … We'll look at Eagle Health Holdings Limited's (ASX:EHH) P/E ratio and reflect on what it tells us about the company's share price. … Eagle Health Holdings has a P/E ratio of 5.04, based on the last twelve months.

Simply Wall St -

Should You Be Excited About Eagle Health Holdings Limited's (ASX:EHH) 21% Return On Equity?

By way of learning-by-doing, we'll look at ROE to gain a better understanding Eagle Health Holdings Limited (ASX:EHH). … Our data shows Eagle Health Holdings has a return on equity of 21% for the last year. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Company Info

Description

Eagle Health Holdings Limited develops, produces, markets, and distributes health food products, and nutritional and dietary supplements in China. It offers donkey hide, amino acids, herbal tea, protein powder, lozenge, enzyme, maca, vitamin, ginseng, birds nest, dendrobium candidum, and heme iron series of products. As of May 12, 2019, the company operated 100 Zhang Lao San stores. The company also produces disposable medical masks. Eagle Health Holdings Limited was founded in 2001 and is based in Xiamen, China.

Details
Name: Eagle Health Holdings Limited
EHH
Exchange: ASX
Founded: 2001
A$53,449,407
368,616,600
Website: http://www.eaglehealthltd.com
Address: Eagle Health Holdings Limited
No.220-228, Meihe 3rd Road,
Xike Light Industrial Park,
Xiamen,
Fujian Province, China
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
ASX EHH Ordinary Shares Australian Securities Exchange AU AUD 03. Jul 2017
CHIA EHH Ordinary Shares Chi-X Australia AU AUD 03. Jul 2017
Number of employees
Current staff
Staff numbers
0
Eagle Health Holdings employees.
Industry
Personal Products
Household
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/03/29 10:55
End of day share price update: 2020/03/27 00:00
Last earnings filing: 2020/02/28
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.